Sign in

CIK 0001833214

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

SAB Biotherapeutics, Inc.

Sign in to watch
Ticker
SABS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
853899721
Phone
+1 305-845-2813
Business address
777 W 41ST ST, SUITE 401, MIAMI BEACH, FL, 33140
Former names
Big Cypress Acquisition Corp.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-03-14 Beyer Russell P Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +275,000 275,000
2022-09-13 Beyer Russell P CHIEF FINANCIAL OFFICER Grant or award · Employee Stock Option (right to buy) +274,875 274,875
2022-03-16 Beyer Russell P Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +6,000 6,000
2021-11-17 Beyer Russell P Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +110,000 110,000
2021-10-26 Beyer Russell P Chief Financial Officer Sale −278 $7.90 $2K 0
2021-10-25 Beyer Russell P Chief Financial Officer Grant or award +129 $7.78 $1K 278
2021-10-18 Beyer Russell P Chief Financial Officer Grant or award +2,475 $10.10 $25K 2,475
2021-09-29 Beyer Russell P Chief Financial Officer Grant or award +10 $10.08 $101 15
2021-09-28 Beyer Russell P Chief Financial Officer Grant or award +149 $10.08 $2K 149
2021-09-28 Beyer Russell P Chief Financial Officer Grant or award +5 $10.07 $50 5

Page 1 of 1 · 10 trades